QUINOLIN DERIVATIVES AS TAM RTK INHIBITORS

• 收藏
• 分享

专利权人:

Qurient Co. Ltd.;Lead Discovery Center GmbH

发明人:

SCHULTZ-FADEMRECHT, Carsten,KIM, Hana,NAM, Kiyean,KIM, Jaeseung,AHN, Seohyun,JEON, Yeejin,LEE, Doohyung,PARK, Dongsik,LEE, SaeYeon,KIM, Jeongjun,AHN, Jiye,JUNG, Chun-won,YANG, Yeong-In

申请号：

DK16716247

公开号：

DK3286177T3

申请日:

2016.04.14

申请国别(地区):

DK

年份:

2020

代理人:

摘要：

The present invention relates to novel compounds which are inhibitors of TAM (Axl, Mer and Tyro 3) and/or Met family receptor tyrosine kinases (RTKs). These compounds are suitable for the treatment of disorders associated with, accompanied by, caused by or induced by a receptor of the TAM family, in particular a hyperfunction thereof. The compounds are suitable for the treatment of hyperproliferative disorders, such as cancer, particularly immune-suppressive cancer, refractory cancer and cancer metastases.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/